About CardioCare AI
Bridging the gap between clinical data and preventive cardiology through transparent, interpretable machine learning.
Understanding the Silent Threat
Cardiovascular Disease (CVD) remains the world's leading killer, claiming approximately 17.9 million lives annually (WHO, 2023). Accounting for nearly 32% of all global deaths, these disorders often progress silently. The majority (85%) of these fatalities are due to heart attacks and strokes — events that are largely preventable with early detection.
CardioCare AI addresses this by shifting the paradigm from reactive treatment to proactive risk assessment. By training on a dataset of 70,000 patient records, our Gradient Boosting model identifies subtle correlations between vitals (Blood Pressure, Cholesterol) and lifestyle habits to project risk levels before clinical intervention becomes urgent.
What Sets Us Apart?
Explainable AI
Every prediction comes with feature importance scores showing exactly which factors — Blood Pressure, Age, Cholesterol — are driving the risk assessment. Full transparency, not a black box.
Clinical Integrity
Trained on 70,000 verified patient records with standardized physiological markers. Features include demographics, vitals, and lifestyle factors validated against clinical research.
Decision Support
CardioCare AI is designed to augment, not replace, medical expertise. It serves as a preliminary screening tool to help identify individuals who may benefit from professional clinical review.
Technology Stack
Ready to Explore?
Try the AI prediction tool, explore the model architecture, or get in touch to discuss collaboration opportunities.